We are live on
!
Find out more
Bioventus
BVS
BVS
66 hedge funds and large institutions have $92.6M invested in Bioventus in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
925% more call options, than puts
Call options by funds: $738K | Put options by funds: $72K
176% more capital invested
Capital invested by funds: $33.6M → $92.6M (+$59.1M)
0.74% more ownership
Funds ownership: 50.46% → 51.2% (+0.74%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less funds holding
Funds holding: 71 → 66 (-5)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
59% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 32
Holders
66
Holders Change
-5
Holders Change %
-7.04%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
13
Reduced
32
Closed
20
Calls
$738K
Puts
$72K
Net Calls
+$666K
Net Calls Change
+$675K
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$2.83M |
| 2 |
Millennium Management
New York
|
-$1.55M |
| 3 |
State Street
Boston,
Massachusetts
|
-$826K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$568K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$392K |
